Initial findings from Project Twenty 21, the UK’s largest medicinal cannabis patient study, indicate the treatment dramatically improves quality of life for people with life-limiting conditions including chronic pain, multiple sclerosis, tourette’s syndrome, epilepsy and post traumatic stress disorder.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The study has now licensed medical cannabis prescriptions to more than 900 patients in substantially poorer health than the general population, and who have been unable to manage their diagnosed conditions with commonly prescribed medicines.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...